|
BMI category (reference: 18.5–24.9 kg/m2)
| | |
|
25.0–29.9 kg/m2
|
1.63
|
1.49–1.78
|
|
30.0–34.9 kg/m2
|
3.19
|
2.92–3.48
|
|
35.0–39.9 kg/m2
|
5.86
|
5.32–6.46
|
|
40+ kg/m2
|
11.58
|
10.46–12.82
|
|
Age group (reference: 18–44)
| | |
|
45–64
|
1.19
|
1.11–1.28
|
|
65–74
|
0.74
|
0.67–0.81
|
|
75–84
|
0.79
|
0.70–0.88
|
|
85+
|
0.75
|
0.63–0.89
|
|
Male
|
0.97
|
0.92–1.02
|
|
Race (reference: White)
| | |
|
Black
|
1.44
|
1.18–1.75
|
|
Other/unknown
|
1.58
|
1.25–2.00
|
|
Index year (reference: 2005)
| | |
|
2006
|
1.35
|
1.21–1.50
|
|
2007
|
1.44
|
1.30–1.60
|
|
2008
|
1.22
|
1.10–1.35
|
|
2009
|
1.30
|
1.17–1.43
|
|
2010
|
0.95
|
0.85–1.04
|
|
2011
|
0.65
|
0.58–0.72
|
|
Smoking status (reference: Never smoke)
| | |
|
Former smoker
|
1.18
|
1.11–1.25
|
|
Current smoker
|
1.15
|
1.07–1.23
|
|
Other/unknown
|
0.40
|
0.35–0.45
|
|
Employment status (reference: Full time)
| | |
|
Not employed
|
1.14
|
1.06–1.23
|
|
Other/unknown
|
1.08
|
1.01–1.16
|
|
Payer status (reference: Commercial)
| | |
|
Medicare
|
1.13
|
1.04–1.23
|
|
Medicaid
|
1.11
|
0.97–1.27
|
|
Other/unknown
|
0.92
|
0.81–1.05
|
|
Covered by Geisinger Health Plan
|
1.23
|
1.16–1.29
|
|
Any cardiac comorbidities
|
1.70
|
1.58–1.83
|
|
Hyperinflammatory state
|
2.08
|
1.83–2.37
|
|
Depression
|
1.14
|
1.02–1.27
|
|
Psychiatric drug
|
1.31
|
1.21–1.43
|
|
Antidepressants/anxiolytics
|
1.19
|
1.12–1.26
|
|
Anti-obesity drug
|
1.39
|
0.81–2.38
|
|
Beta blocker
|
1.04
|
0.98–1.10
|
|
Antihyperlipidemia drugs
|
1.38
|
1.30–1.47
|
|
Antihypertensives
|
1.32
|
1.24–1.40
|
|
Any outpatient encounters
|
0.66
|
0.57–0.76
|
|
Any inpatient encounters
|
1.31
|
1.19–1.43
|
|
Any emergency department encounters
|
1.03
|
0.95–1.12
|
|
Log of total encounter costs
|
1.17
|
1.14–1.19
|
|
C statistic = 0.79
| | |
